Home / Intelligence / Webinars / Brand Health 2022: A Strategic, Data-Driven Approach to Brand Assessment
Available On Demand
December 1st, 2021 | 1:00 pm EST
In today’s highly competitive market, innovation and creativity are critical to create a strong Brand Strategy that supports meaningful differentiation. A key challenge for life sciences companies in 2022 will be to identify the clearest strategies to address brand performance and assessing brand health for their unique context. Whether your brand is on-market already or is preparing for launch, leveraging a nuanced, evidence-based view of performance drivers – from prescriber adoption, to payer acceptance, to patient persistence – is essential to making the best decisions. Come join RWE and Brand Strategy experts from Trinity as they lead a lively discussion around the breadth and depth needed to construct an enlightening and actionable brand health assessment.
Key Webinar Topics:
- Sharing Trinity’s Brand Planning Optimization Process
- Calibrating the scale of an evidence-based health assessment for each unique situation and context
- Integrating Brand Health insights into brand strategy, planning, and tactics
Complete the form below to watch the recording of the webinar.
Omnichannel Orchestration After Patient Finding: Once You’ve Found The Patients, What Do You Do?
March 7, 2024 | 1:00 – 1:45 PM ET
Across life sciences commercialization organizations, attention is shifting to best practices in strengthening the connection between healthcare professionals (HCPs) and patients. Join Susheel Sukhtankar, Partner and Head of Commercial Analytics at Trinity Life Sciences, as he hosts a dynamic discussion on the nuances of omnichannel orchestration with panelists Jerry Luciano, Vice President of Omnichannel Marketing […]
Sign Up Now
Learn From the Past – Launch Better Tomorrow
Available On Demand
Whether you are an emerging, mid-tier or large-tier company preparing for launch, this webinar is a must-watch. Join us for an informative webinar as our experts dive into Trinity Life Sciences’ latest white paper, the Trinity Annual Drug Index—an evaluation of commercial performance over three years of 58 novel drugs approved in 2020. Hear from […]
Trinity Annual Drug Index
This report, the sixth in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the commercial performance over three years of novel drugs approved by the FDA in 2020, with commercial, therapeutic […]